BG
RMD icon

Bollard Group’s ResMed RMD Stock Holding History

Bollard Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed – – 305
2025
Q1 		$0 Hold
1
– – ﹤0.01% 286
2024
Q4 		$0 Hold
1
– – ﹤0.01% 298
2024
Q3 		$0 Hold
1
– – ﹤0.01% 303
2024
Q2 		$0 Hold
1
– – ﹤0.01% 303
2024
Q1 		$0 Hold
1
– – ﹤0.01% 308
2023
Q4 		$0 Hold
1
– – ﹤0.01% 343
2023
Q3 		$0 Sell
1
-15
-94% -$2.71K ﹤0.01% 612
2023
Q2 		$4K Buy
16
+15
+1,500% +$3.34K ﹤0.01% 447
2023
Q1 		$0 Hold
1
– – ﹤0.01% 294
2022
Q4 		$0 Hold
1
– – ﹤0.01% 291
2022
Q3 		$0 Hold
1
– – ﹤0.01% 295
2022
Q2 		$0 Sell
1
-1,288
-100% -$274K ﹤0.01% 384
2022
Q1 		$313K Sell
1,289
-200
-13% -$48.4K 0.01% 194
2021
Q4 		$388K Buy
1,489
+3
+0.2% +$778 0.01% 183
2021
Q3 		$392K Buy
1,486
+2
+0.1% +$547 0.01% 182
2021
Q2 		$366K Buy
1,484
+2
+0.1% +$420 0.01% 179
2021
Q1 		$287K Buy
1,482
+1
+0.1% +$201 0.01% 191
2020
Q4 		$315K Hold
1,481
– – 0.01% 170
2020
Q3 		$254K Buy
1,481
+1
+0.1% +$185 0.01% 181
2020
Q2 		$284K Buy
+1,480
New +$242K 0.01% 166

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bollard Group's RMD Position: Q2 2025 in Review

Bollard Group sold out of ResMed (RMD) in Q2 2025, closing a stake of 1 share.

Bollard Group first reported a position in RMD in Q2 2020 and held it in 20 quarters. The position peaked at $392K in Q3 2021. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Bollard Group reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Bollard Group sold 1 ResMed share in Q2 2025.
  • Bollard Group first reported a position in ResMed in Q2 2020 and held it in 20 quarters.
  • Bollard Group's ResMed position peaked at $392K in Q3 2021.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.